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Folklore studies have revealed that Musa balbisiana Colla (MB; Family: Musaceae)
has high medicinal properties. The purpose of the present study is to evaluate
antihyperglycemic, and antioxidant activity of MB extracts in streptozotocin (STZ)
induced diabetic rats. In vitro antioxidant and antidiabetic activity of MB extracts, i.e.,
root extract (RE), shoot extract and inflorescence extract were determined by using
various methods viz 1,-1-diphenyl-2-picrylhydrazyl (DPPH) and a method to assess their
possible effect on glucose diffusion across gastrointestinal tract and identify bioactive
compound of potent extract. In vivo antilipidemic and antidiabetic activity was evaluated
by administrating oral dose of RE for 15 days on STZ- induced diabetic rat. RE showed
highest antioxidant activity by scavenging DPPH radical (IC50 32.96 µg/ml) and inhibit
30% glucose movement in vitro. The methanol extract of root showed the presence
of calyx [4] arene category of the compound. Furthermore, RE treated rat revealed a
reduction in fasting blood glucose (62.5%), serum total cholesterol (36.2%), triglyceride
(54.5%), and low-density lipoprotein (50.94%) after 15 days as compared to STZ
treated animal. There was an initiation of regenerative structures of the affected organs
after 15 days of RE treatment. Histopathological observations clearly differentiate the
structural changes in pancreas, liver, and kidney of STZ and RE treated group. The
presence of calyx [4] arene class of compound may be responsible for its antioxidant
and antidiabetic properties by absorbing glucose in vivo.
Keywords: antioxidant, free radical, crude fiber, hyperglycemia, hyperlipidemia
INTRODUCTION
Diabetes mellitus (DM) is one of the severe endocrine disorder and an important health problem
that has been increasing in most of the countries (Mbanya et al., 2010). According to the
report of World Health Organization [WHO], (2013) about 347 million people suffer from
diabetes worldwide. After cancer and cardiovascular diseases, diabetes has become pandemic to
mankind due to its high prevalence, morbidity, and mortality (Egede and Ellis, 2010). According
to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA),
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American biopharmaceutical companies developed 180 new
antidiabetic medicines. These drugs are under development,
either in clinical trials or under review by the Food and Drug
Administration (FDA). It includes 30 drugs for type 1 diabetes,
100 for type 2 and 52 for diabetes-related conditions. DM
is a metabolic disorder characterized by hyperglycemia and
insufficiency in secretion and action of endogenous insulin
and disturbances of carbohydrate, lipid and protein metabolism
(Ansarullah et al., 2011).
A wide range of oral medicines are currently being used
considering the major impact of the increasing global prevalence
of diabetes due to the absence of efficient and affordable
interventions (Inzucchi, 2002). In most of the cases, the
antidiabetic medications prescribed by physicians are responsible
for various side effects such as liver problems, lactic acidosis,
diarrhea and high rates of secondary failures (Inzucchi, 2002).
So the traditional system of medicinal plants and practice has
been a necessary resource in many countries to control various
complications of DM as they are considered to be less toxic and
free from side effects than synthetic molecules (Balaraman et al.,
2010).
Among the numerous fruit yielding plants, that provide
medicinal properties banana is a major fruit, contributing 16%
of the world total fruit production (Reported by Food and
Agricultural Research, Geneva, 2009). It has been reported that
there are 30 different varieties of banana (Family: Musaceae)
available in the world (Lehmann et al., 2002). Various parts of the
plant can be used for the treatment of various diseases including
diabetic, diarrhea, scabies and inflammations as all parts of
the plant exhibit different pharmaceutical properties (Rai et al.,
2009). To get low−fat, low−sodium, and cholesterol−free diet,
the banana is suitable for consumption making it particularly
recommendable for people with cardiovascular and kidney
problems, arthritis, gout, or gastrointestinal ulcers (Sumathy
et al., 2011). Among the different varieties of Musa sp., Musa
balbisiana Colla (MB; Family: Musaceae) is available in South
Asia, Southeast Asia, and Southern China. The inflorescence and
shoot part of the plant have nutritional properties. The ripe pulp
of the MB is widely used as baby food instead of commercially
available food for children. From shoot and root part of MB, a
food additive is known as “Kolakhar” is prepared which can also
be used as soap and detergents for washing cloth, shampooing
hair, and antibacterial agent.
Much study has been done regarding the various medicinal
properties of different Musa sp. It was reported that M. sapientum
L. (Family: Musaceae) fruits increases insulin secretion by
pancreatic β-cells and enhances peripheral glucose utilization,
in STZ induced rat (Ojewole and Adewunmi, 2003). Folklore
studies revealed that root extract (RE), shoot extract (SE), and
inflorescence extract (IE) of MB have high medicinal properties,
and the RE is used for the treatment of diabetes (Tribal
Healthcare Research Programme, April 2008–March 2012).
However, no scientific study has been designed till date regarding
the scientific validation of this traditional claim. Therefore an
attempt has been made to investigate some pharmacological
property of these three extracts of MB with special reference to
antidiabetic, antilipidemic, and antioxidant property.
MATERIALS AND METHODS
Chemicals
1,-1-diphenyl-2-picrylhydrazyl (DPPH), trolox, ascorbic acid
(AA), thiobarbituric acid (TBA), superoxide dismutase (SOD),
catalase (CAT), glutathione (GSH), 5,-5-dithiobis-2-nitrobenzoic
acid (DTNB), catechin, quercetin, streptozotocin (STZ) were
obtained from Sigma Chemicals (St. Louis, MO, USA). All the
other chemicals used in the study were obtained from Merck,
India.
Plant Materials
Plant materials (root, shoot, and inflorescence) were collected
from the medicinal plant garden of Institute of Advance Study in
Science and Technology (IASST), Guwahati, Kamrup district of
Assam, India (situated in between 25◦43′–26◦53′ North latitude
and 90◦39′–92◦11′ East longitude), in the month from November
to April. The plant was authenticated and reconfirmed in the
Department of Botany, Gauhati University, Assam. A voucher
specimen (IASST/LSD/PM-18) was deposited at the medicinal
and aromatic plant section, Life Sciences Department of IASST,
Assam.
Preparation of Plant Extracts
Root, shoot, and inflorescence were shed dried and grinded into
fine powder. Each 1 gm of sample was dissolved in 10 ml of
distilled water (1/10, w/v) and kept on a magnetic stirrer for
60 min at 30◦C. The solutions obtained were filtered with the
muslin cloth and stored at −20◦C until use. No preservatives
were added.
Antioxidant Assay
DPPH Radical Scavenging Activity
The DPPH (1,-1-diphenyl-2-picrylhydrazyl) scavenging effects of
RE, SE, and IE of MB were determined by a standard method
(Brand-Williams et al., 1995). In 2.0 ml of each sample, 2.0 ml
of 0.16 mM DPPH solution were added. The mixture was
vortex for 1 min and kept in the dark at room temperature for
30 min. The absorbance of each sample was measured at 517 nm.
The scavenging effect expressed (%) was calculated using the
following given Duan’s formula. Commercially available AA was
used as the standard.
Scavenging effect (%) = [1 − (Asample − Asample blank)/
Acontrol1] × 100
Where the Acontrol is the absorbance of the control (DPPH
solution without sample), the Asample is the absorbance of the test
sample (DPPH solution plus test sample), and the Asample blank
is the absorbance of the sample only (sample without DPPH
solution).
Hydrogen Peroxide (H2O2) Radical Scavenging
Activity
The radical scavenging activity of the samples against H2O2
was determined using the method of Ruch et al. (1989). H2O2
(43 mM) was prepared in 0.1 M phosphate buffer solution (pH
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7.4). Samples (1 ml) were mixed with 43 mM hydrogen peroxide
solution. After 10 min, the reaction mixture absorbance was
measured at 230 nm. The phosphate buffer without hydrogen
peroxide was used as blank. Trolox was used as a reference
compound.
The inhibition activity was calculated as:
Percentage scavenged (H2O2) = [(A0− A1)/A0] × 100
Where A0 is absorbance of the control and A1 is absorbance of
the samples.
Nitric oxide (NO) Radical Scavenging Activity
Nitric oxide radical scavenging activity was carried out as per the
method of Sreejayan and Rao (1997). NO radicals were generated
from sodium nitroprusside solution. Sodium nitroprusside 1 ml
(10 mM) was mixed with 1 ml of RE, SE and IE of MB
in 200–1000 µg/ml in phosphate buffer (0.2 M pH 7.4). The
mixture was incubated at 25◦C for 150 min. After incubation, the
reaction mixture was mixed with 1.0 ml of Griess reagent (1%
naphthalenediamine dichloride and 2% phosphoric acid). The
absorbance was measured at 546 nm and percentage of inhibition
was calculated using the above formula. AA used as a standard.
Lipid peroxidation (LPO)
Lipid peroxidation induced by Fe2+ ascorbate system in rat
liver homogenate was estimated as thiobarbituric acid reactive
substances (TBARS) by the method of Ohkawa et al. (1979). The
reaction mixture contained rat liver homogenate 0.25 ml (10%
w/v in 0.05 M phosphate buffer, pH 7.4), 0.1 ml Tris-HCl buffer
(150 mM, pH 7.2) and 0.05 ml AA (0.1 mM), 0.05 ml 4.0 mM
FeSO4.7H2O and 0.05 ml of RE, SE, and IE of MB. The mixture
was incubated at 37◦C for 1 h and to it was added 1.5 ml of 0.8%
(w/v) 2-thiobarbituric acid, 1.5 ml of 20% acetic acid and 0.2 ml
of 8.1% (w/ v) sodium dodecyl sulfate (SDS). Then the volume of
the mixture was increased up to 4.0 ml with distilled water and
heated at 95◦C for 60 min. After cooling with tap water, 1.0 ml of
distilled water and 5.0 ml of a mixture of n-butanol and pyridine
(15:1, v/v) were added. The mixture was shaken vigorously and
centrifuged at 5000 rpm for 10 min. The absorbance of the
developed color in the organic layer was measured at 532 nm.
Data were expressed as nanomoles per mg tissue mass. Catechin
was used as a standard.
Phytochemical Analysis
Total Polyphenol Content
Total phenolic contents of all the three extracts were determined
by Folin and Ciocalteu reagent using the method of Hagerman
(2002) with slight modifications. All the three extracts (0.5 ml)
were mixed with Folin and Ciocalteu reagent (2.5 ml, diluted
10 times) and incubated for 2 min at room temperature
followed by addition of sodium carbonate solution (2 ml, 7.5%
w/v). The mixture was then allowed to stand for 30 min at
room temperature and absorbance was measured at 765 nm.
The amount of total polyphenol was calculated as a catechin
equivalent from the calibration curve of standard catechin
solution and expressed as mg catechin/gm of extract.
Total Flavonoid Content
Total flavonoid was estimated according to the method of Jay
et al. (1975). RE, SE, and IE, 2 ml of each was mixed with 2 ml
of AlCl3 in methanol (2%). The absorbance was read at 415 nm
after 10 min. Quercetin was used as reference compound, and the
result was expressed as mg of quercetin equivalents (QE)/gm of
extract.
Crude Fiber
Crude fiber was estimated following the method of Lanna et al.
(2004). Extract (2 gm) was boiled with ether up-to 52◦C to
remove fat. It was then mixed with 200 ml of sulphuric acid
(H2SO4) for 30 min and remaining was filtered through muslin
cloth and washed with boiling water until the complete removal
of acid. After washing, it was boiled with sodium hydroxide
solution for 30 min. The above solution was again filtered and
washes with 25 ml of 1.25% H2SO4, three 50 ml portions of water
and 25 ml alcohol. After removing the residue, it was transferred
to ashing dish (pre-weighed dish W1). The residue obtained was
then dried for 2 h at 130± 2◦C and cooled in the desiccators and
weigh (W2). It again ignited for 30 min at 600± 15◦C and cooled
in a desiccator and weigh (W3).
% of crude fiber was calculated using the following
formula = Loss in weight on ignition (W2–W1) – (W3–W1)/
weight of the sample× 100.
Glucose Movement Studies
A simple model system was used to evaluate effects of plant
extracts on glucose movement in vitro. This model was adapted
from a method described by Edwards et al. (1988), which
involved the use of a sealed dialysis tube into which 15 ml of
a solution of glucose and NaCl (0.15 M) was introduced, and
the appearance of glucose in the external solution was measured.
The model used in the present experiment consisted of a dialysis
tube 6 cm × 15 mm; (Spectra/P or MWCO: 2000) into which
2 ml of 0.15 M NaCl containing 0.22 mM D-glucose was added.
The dialysis tube was sealed at each end and placed in a 50 ml
centrifuge tube containing 45 ml of 0.15 M NaCl. The tubes
were placed on an orbital shaker (Tarson product) and kept at
room temperature (20 ± 2◦C). The movement of glucose into
the external solution was monitored at set time intervals, as
illustrated in the figure. In the experiment, the effects of 60 gm/l
plant extracts on glucose diffusion were compared to control
test conducted in the absence of plant extract. At the end of
the experimental period, the concentrations of glucose within
the dialysis tubing were measured. All tests were carried out
in triplicate. Glucose concentrations were measured using the
glucose oxidase method of analysis.
GCMS Analysis
The GC – MS analysis was carried out using a GCMS-TQ8030
(Shimadzu Corporation, Kyoto, Japan). An EB-5MS capillary
column (30m × 0.25 mm i.d.; 0.25 µm) was used for GC.
The instrument was set to a pressure of 57.4 kPa and initial
temperature of 50◦C and maintained at this temperature for
2.5 min. At the end of this period, the oven temperature was rise
to 300◦C, at the rate of 15◦C/min, and maintained for 8 min.
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Injection port temperature was ensured at 300◦C and Helium
flow rate as 1 ml/min. The ionization voltage was 70 eV. The
samples were injected in split mode as 20:1. Mass spectral scan
range was set at 45–450 (m/z). Compound identification was
involved comparison of the spectra with the databases (NIST-11)
using a probability based algorithm.
Preparation of STZ Induced Diabetic
Rats
The experiment was conducted using healthy male Wister albino
rat (110–150 gm) in accordance with the internationally accepted
guideline for experimental animal use and care, and the study was
approved by the Institutional Animal Ethics Committee (IAEC;
1706/GO/C/13/CPCSEA). Animals were housed in individual
cages in an ambient temperature of 27 ± 3◦C and relative
humidity 50 ± 5% with a 12 h light-12 h dark cycle. They
were fed pellet diet consisting of nitrogen free extract 51.65%,
crude protein 21.36%, crude fat 10.63%, total ash 7.41%, moisture
6.32%, crude fiber 2.63%, calcium 1.75%, phosphorous 1.1%,
water activity 0.23% per 100 gm of the diet; Nutrilab, Kolkata,
India and distilled water.
Acute Toxicity Evaluation in Mice
Acute oral toxicity study was performed as per OECD 423
guidelines (acute toxic class method), albino mice (n = 6) of
either sex selected by random sampling were used for acute
toxicity study. The animals were kept fasting overnight and
provided only with water, after which the RE was administered
orally at 5 mg/kg and observed for 15 days. If mortality is
observed as two out of three animals, then the dose administered
is assigned as a toxic dose. If mortality observed in one animal,
then the same dose is repeated to confirm the toxicity study. If
mortality is not observed, the procedure is repeated for higher
doses such as 1000, 2000, and 3000 mg/kg.
Animal Treatment
Diabetes was induced by a single intraperitoneal (i/p) injection
of STZ (55 mg/kg in 0.1 M citrate buffer, pH 4.5; Srinivasan
et al., 2005). Blood glucose concentration and changes in body
weight were regularly monitored. After 3 days, rats with diabetes
having hyperglycemia [i.e., with fasting blood glucose (FBG) of
250–400 mg/dl] were taken for the experiment. Three different
doses were selected based on the traditional claim, i.e., 50, 100,
and 200 mg/kg of RE for the animal experiment. Among them,
100 mg/kg was found to be most effective. Hence, this dose has
been selected for the present study. The rats were divided into
four groups of six rats each as follows:
Group A: Received only normal pellet diet and water ad
libitum.
Group B: STZ (55 mg/kg) treated hyperglycemic group.
(Srinivasan et al., 2005).
Group C: Extract treated (100 mg/kg) group.
Group D: Glibenclamide (10 mg/kg) treated group (Gupta
et al., 2012).
At the end of the stipulated period (15 days), the animals
were sacrificed after overnight fasting and blood were collected
from jugular vein (Tiwari et al., 2014) and serum was separated
by centrifugation. Pancreas, liver and kidneys were isolated,
washed with ice-cold saline and preserved for biochemical and
histopathological analysis.
Long-Term Effect of RE on FBG, Body Weight and
Water Intake
Fasting blood glucose, body weight and water intake were
measured on day 1st, 5th, 10th, and 15th day of the experiment.
FBG was measured by using glucometer (Accu-Check Active
Roche, Germany).
Metabolic Parameters
Total cholesterol (TC), serum triglyceride (TG), and high-
density-lipoprotein-cholesterol (HDL-c) were determined
using enzymatic kits (Crest Biosystems, Goa). Low-density-
lipoprotein-cholesterol (LDL-c) and very low-density
lipoprotein- cholesterol (VLDL-c) were calculated using
Friedwald’s formula (Friedewald et al., 1972).
Endogenous Oxidants and Oxidative Stress Markers
Endogenous antioxidants, such as GSH by Ellman (1959); SOD
by Marklund and Marklund (1974) and CAT by Góth (1991) were
measured. TBARS was measured as a marker of LPO by using
the procedure described by Ohkawa et al. (1979). Nitrate/nitrite
levels were measured by using the standard method described by
Green et al. (1982).
Total Antioxidant Activity (TAA)
The antioxidant activities were measured with a Photochem
system (Analytik Jena AG, The Woodlands, TX, USA). The
system enables the quantification of antioxidant capacity of blood
serum and liver homogenate based on photo chemiluminescence
(PCL). This includes photochemical excitation to generate free
radicals (superoxide anion radicals) followed by luminescence
detection method Popov and Lewin (1999). The free radicals
generated by the optical excitation of the photosensitizer
substance were partly eliminated by the reaction of antioxidants
in the sample to be analyzed. In a measurement cell, the
luminescence of the detection material (luminol) generated by
the remaining radicals is measured and thus the quantity of
antioxidants present in the sample was determined in equivalents
to AA. PCL can measure antioxidant activity in the nano molar
range whereas other antioxidant assays determine activity in the
micro molar range. The reagent kits (ACW) used for the analysis
were obtained from Analytik Jena AG. 10 µl for serum and 2 µl
of liver homogenate were used for each measurement.
Pathological Histology
For histopathological analysis of pancreas, liver and kidney,
samples were collected from all groups and fixed in 10% buffered
formalin. After routine processing, the tissues were embedded in
paraffin by using Leica Histopathology Assembly (Leica TP 1020
and Leica EG 1150 H), sectioned at 5µm and stained with routine
haematoxylin-eosin (H-E) in Leica Autostainer XL. After staining
images were obtained under Phase contrast microscope (Leica).
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Statistical Analysis
All data are presented as mean± SEM. In vitro antioxidant values
of RE, SE, and IE was tested using one-way analysis of variance.
Data from group A, B, C, and D were tested by two-way analysis
of variance followed by Bonferroni’s post hock test. All statistical
analysis were performed using Graph Pad Prism version 5 for
Windows. The P-value of <0.001 was considered as statistically
significant.
RESULTS
DPPH and H2O2 Free Radical
Scavenging Activity
The three extracts showed a concentration dependent scavenging
activity against DPPH and H2O2 radicals. IC50 values of the RE,
SE, and IE against DPPH free radical was found to be 32.96, 42.4,
and 38 µg/ml, respectively, which could be comparable with the
AA with an IC50 value of 36.6 µg/ml. In the case of H2O2, the
IC50 values were 57.6, 36.8, and 40.8 µg/ml, respectively, while
that of trolox showed an IC50 value of 42.8 µg/ml.
LPO and NO Inhibition Assay
In the case of LPO, IC50 values of RE, SE, and IE were found to be
23.96, 39.09, and 44.88 µg/ml, respectively, and that of catechin
is 25.99 µg/ml. The NO radical also scavenged by three extracts
and their 50% inhibitions were 33.99, 45.09, and 39.77 µg/ml,
respectively, and the AA was 30.56 µg/ml.
Phytochemical Analysis
Total Polyphenol and Flavonoid Content of RE, SE,
and IE of MB
Total polyphenol content quantified in RE, SE, and IE were
3.88± 0.0057, 0.69± 0.00057, and 2.51± 0.032 mg catechin/gm
of extract, respectively. Flavonoid content of RE, SE, and IE were
0.24± 0.015, 0.80± 0.006, and 0.065± 0.0085 mg quercetin/gm
of extract, respectively. Among the three extracts, RE showed
highest amount of polyphenol followed by IE and SE.
Crude Fiber in RE, SE, and IE
The amount of crude fiber in RE, SE, and IE were 4.01 ± 0.00,
4.01 ± 0.001, and 2.50 ± 0.001 gm/100 gm of the whole extract,
respectively. RE have the highest amount of crude fiber as
compared to SE and IE.
Effect of RE, SE, IE on Glucose Diffusion
After 30 h without plant extract (control), glucose movement out
of dialysis tube had reached maximum level with a mean glucose
concentration in the external solution was 0.16 ± 0.009 mg/ml.
RE of MB was the most potent inhibitor of glucose movement
in the model system with external glucose concentration
0.099 ± 0.004 mg/ml after 30 h. In the case of SE and IE,
the concentration of glucose in the external medium after
30 h was found to be 0.1 ± 0.01 and 0.14 ± 0.01 mg/ml,
respectively.
GC-MS Analysis
After GC-MS analysis of methanol extract of RE,
different compound were identified, but among them the
compound which showed highest concentration was
Pentacyclo[19.3.1.1(3.7).1(9.13).1(15.19)]octacosa-1(25),3(28),4,
6,9(27),10,12,15(26),16,18,21,23-dodecaen-25, 26, 27, 28-tetrol
(Figure 1).
Acute Toxicity Effect
The results of the acute oral administration of RE of MB in
various doses of 1000, 2000, and 3000 mg/kg indicated no
mortality up to 15 days after treatment.
During the experimental period of 15 days, four animals died
in Group B, Group C, and Group D after STZ treatment.
Long-Term Effect of RE on FBG
Fasting blood glucose level significantly increased about 62.5%
in case of group B compared to group A. Treatment of group D
with glibenclamide restored blood glucose to almost normal level.
Interestingly, a similar effect was observed in rats administrating
RE of MB (group C) at a dose of 100 mg/kg (Figure 2A).
Effect of RE on Body Weight and Water
Intake
Body weight of group B was decreasing day by day from the 1st
to 15th day (131–111.67 gm) of the experiment. On the contrary,
it has been found that the group C animals were gaining their
weight from 111.67 g to 133.33 gm (Figure 2B). Water intake of
group B was increasing day by day, and the amount was much
higher (55 ± 5 ml) than the group A. In the case the of group
C it has been found that the water intake volume (24 ± 5.77 ml)
became less as compared to group B (Figure 2C)
Effect of RE on Serum Lipid Profile
Serum lipids (TC, TG, VLDL-c, and LDL-c) were increased
significantly (p < 0.05) in diabetic animals in comparison to that
of Group A (Table 1). However, these parameters were decreased
significantly (p < 0.01) in the group C (about 54.9% for VLDL-
c and 50.94% for LDL-c). HDL-c, a beneficial lipoprotein, was
decreased in group B as compared to that of group A, and the
result reversed in group C (p < 0.01; Table 1).
Effect of RE on Endogenous Antioxidants
and Oxidative Stress Markers
Lipid peroxidation level was elevated significantly in group B
compared to group A. Administration of RE (100 mg/kg) reduced
the LPO level significantly on the 15th day (Table 1). The GSH
level was found to be low in the liver and serum of group B
(p < 0.01) while in the group C the levels increased on the
15th day when compared with the untreated diabetic animals
(p < 0.01; Table 1). The SOD activity was found to be reduced in
the liver and serum of animals treated with STZ (p < 0.01). SOD
values in rats treated with STZ along with RE was significantly
higher (p< 0.01) on the 15th day (Table 1). In liver and serum of
diabetic rat, NO level was found to be more as compared to that
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FIGURE 1 | Typical GC-MS chromatogram of Musa balbisiana methanolic root extract. Major compound identified as (1) Pentacyclo[19.3.1.1(3.7).1(9.13).
1(15.19)] octacosa1(25),3(28),4,6,9(27),10,12,15(26),16,18,21,23-dodecaen-25, 26, 27, 28-tetrol.
of control (Table 1). RE and glibenclamide treated groups showed
a lower level of NO as compared to the diabetic control group.
TAA of Serum and Liver
The TAA in the serum and liver of group A, group B, group C,
and group D were quantified in equivalents to AA. Serum TAA
in group A, group B, group C, and group D were 0.95 ± 0.0049,
0.1± 0.14, 1.09± 0.27, and 1.6± 2.0 nmol/ml, respectively. Liver
TAA in group A, group B, group C, and group D were 2.3± 0.05,
0.71± 0.7, 2.2± 0.28, 2.5± 0.21 nmol/mg of tissue, respectively.
A high TAA was observed in the liver and serum of group C as
compared to group B.
Histopathological Changes
Pancreas
HE-stained tissue sections of group B elicited severe injury
of pancreatic β-cells, such as the decrease of the islet cells
numbers, damage of acinar cells (Figure 3B) as compared to
FIGURE 2 | Effect of Musa balbisiana root extract on different parameters. (A) Fasting blood glucose (FBG) (B) Body weight changes (C) Water intake. All the
results were expressed in mean ± SEM (n = 6); ∗∗∗p < 0.001 in comparison between different groups.
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TABLE 1 | Changes in levels of serum lipid profile (TC, TG, HDL-c, LDL-c, and VLDL-c) and oxidative stress markers (SOD, GSH, Catalase, TBARS, and
NO) in serum and liver in groups A, B, C, and D.
Parameters Group A Group B Group C Group D
Serum lipid profile
TC (mg/dl) 70.34 ± 1.9 186.23 ± 34.13+ 119.36 ± 6.01∗∗ 111.1 ± 4.1
TG (mg/dl) 120 ± 0.86 149.40 ± 8.28 127.54 ± 7.63∗ 129.29 ± 7.61
HDL-c (mg/dl) 37.66 ± 0.89 21.90 ± 2.58 30.33 ± 5.55 34.33 ± 10.12
LDL-c (mg/dl) 56.76 ± 1.49 194.21 ± 5.57++ 114.53 ± 3.40∗ 102.62 ± 7.5
VLDL-c (mg/dl) 24 ± 0.17 29.88 ± 5.6 25.50 ± 3.45 25.85 ± 3.45
Oxidative stress markers
Serun SOD (% SOD) 33.52 ± 1.34 22.19 ± 3.00+ 48.79 ± 8.9∗∗ 48.66 ± 0.57
Serum GSH (ug/ml) 1300.67 ± 49 1134.66 ± 54.45 2552 ± 579.75 2873.33 ± 148.4
Serum catalase (unit mg protein) 152.71 ± 2.4 44 ± 6.55++ 112.06 ± 17.52∗∗ 115.53 ± 12.78
Serum TBARS (nmole/ml) 28.7 ± 2.23 37.7 ± 4.66 23.24 ± 6.07 20.56 ± 4.56
Serum NO (uM/ml) 23.19 ± 4.11 30.92 ± 5.89 25.03 ± 2.33 24.29 ± 3.56
Liver SOD (% SOD) 68 ± 0.89 32.29 ± 10.39+ 57.71 ± 3.03 61.65 ± 6.24
Liver GSH (ug/gm) 1361.33 ± 120.3 896 ± 148.1++ 1364.66 ± 30.74 1416.66 ± 104
Liver catalase (unit mg protein) 26.12 ± 2.42 17.50 ± 2.42+ 39.02 ± 1 42.03 ± 2.61
Liver TBARS (nmole/mg tissue) 31.23 ± 2.4 50.3 ± 1.48++ 22.85 ± 0.18 24.91 ± 4.96
Liver NO (uM/mg) 23.92 ± 5.67 40.91 ± 3.44 28.61 ± 6.11 27.60 ± 5.55
∗p < 0.05 vs. diabetic control, ∗∗p < 0.01 vs. diabetic control, +p < 0.05 vs. control, ++p < 0.01 vs. control. n = 6, mean ± SEM.
group A (Figure 3A). Group D (glibenclamide, 10 mg/kg)
showed a significant effect on reducing injuries of the pancreas
(Figure 3D). The damage in the pancreas was partially reversed
in group C (Figure 3C).
Liver
In liver tissue degeneration of hepatocytes, dissolved cytoplasm,
necrosis, congestion in central vein and intrahepatic
hemorrhages were observed in group B (Figure 4B). After
the administration of RE of MB (group C) severe hepatic lesions
induced by STZ were markedly reduced (Figure 4C). Group B
(Figure 4D) showed mild to moderate intrahepatic hemorrhages
and few erythrocytes in the central vein as compared to group A
(Figure 4A).
Kidney
Wider bowman’s space, severe hemorrhages in glomeruli, mild
intertubular hemorrhages, and mild dilatations were observed
in group B (Figure 5B). The kidney of group C showed
mild intertubular hemorrhages and restoration of glomeruli
with few erythrocytes (Figure 5C). Group D showed moderate
hemorrhages in glomeruli (Figure 5D) in comparison to group A
(Figure 5A).
DISCUSSION
Musa balbisiana Colla has high medicinal properties, which
is used for the treatment of diabetes, cardiovascular disease,
inflammation, etc., from time immemorial in different parts of
the world without any scientific basis. For this reason, we have
screened out the different extracts of MB for its antioxidant,
antilipidemic and antidiabetic activity. In this study, RE of MB
shows a high antioxidant activity than that of SE and IE. RE
scavenged DPPH, H2O2, NO radicals and caused inhibition
of LPO in an efficient way. Antioxidant plays a significant
role in scavenging highly reactive free radicals. Reactive oxygen
species (ROS) such as H2O2, superoxide (O·−2 ) and hydroxyl
(.OH) radicals are responsible for OS at the time of diseased
condition, as supported by increased cellular accumulation
of lipid peroxides and depletion of endogenous antioxidants
(Dhalla et al., 2000). OS in diabetes coexists with a reduction
in the antioxidant status, which can increase the deleterious
effects of free radicals. In diabetes, OS may occur due to auto-
oxidation of glucose, shifts in redox balances, decreased tissue
concentrations of low molecular weight antioxidants, such as
reduced glutathione (GSH) and impaired activities of antioxidant
defense enzymes such as SOD, CAT, and increase MDA level
in the body (Haskins et al., 2003). ROS generated by high
glucose is causally linked to other metabolic abnormalities
important to the development of diabetic complications. Besides
this, RE was the most potent inhibitor in glucose movement
tested in an in vitro glucose diffusion model. The in vitro
glucose diffusion model employed constant agitation to mimic
gastrointestinal convection (Edwards et al., 1987). This inhibition
of glucose movement of RE may be due to the presence of
complex carbohydrate. Dietary fiber which is the part of plant
material includes different types of complex carbohydrate can
influence gastrointestinal physiology and also the absorption and
metabolism of carbohydrate and fat. The fiber present in RE may
be responsible for absorption and metabolism of carbohydrate;
hence, the concentration of glucose outside the dialysis tube was
less as compared to that of SE and IE.
The chromatogram for methanol extract of root showed the
presence of Pentacyclo[19.3.1.1(3.7).1(9.13).1(15.19)]octacosa1
(25),3(28),4,6,9(27),10,12,15(26),16,18,21, 23-dodecaen-25, 26,
27, 28-tetrol with retention time 26.91 min]. This compound is
a derivative of calyx [4] arene class of compound, which act as
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FIGURE 3 | Fibrosis in pancreas. (B) Represents Hematoxylene Eosine
staining of streptozotocin (STZ) induced pancreatic section, showing fibrosis
in the β-cells of pancreas (represented by arrow). (A) Represents normal
pancreas with acinar cells. (C) It is the root extract (RE (100 mg/kg) treated
pancreatic section, showing improvement in pancreatic structure and
(D) represents glibenclamide (10 mg/kg) treated pancreatic section showing
reversal of the normal pancreatic structure.
FIGURE 4 | Congested central vein. (B) Represents Hematoxylene Eosine
staining of STZ induced liver section, showing congestion in central vein
(represented by arrow). (A) represents normal sized central vein. (C) It is the
RE (100 mg/kg) treated liver section, showing improvement in the hepatic cell
structure and (D) represents glibenclamide (10 mg/kg) treated liver section,
showing development in the hepatic structure.
metal chelating agent and conjugate with Zn2+ or Mg2+ and
perform its activity (Pathak et al., 2011).
Administration (i/p) of STZ reduced the body weight of the
experimental animals significantly within 3 days, which was
retained after 15 days of RE treatment in group C (p < 0.001).
Derangement of metabolic pathways leads to decrease in body
weight, and it is a common feature of diabetes (Al-Shamaony
et al., 1994). The loss of body weight in STZ induced diabetes
might be due to the increased muscle waste and loss of tissue
FIGURE 5 | Increase in bowman’s space of kidney. (B) Represents
Hematoxylene Eosine staining of STZ induced kidney section, showing wider
bowman’s space (represented by arrow). (A) Represents normal kidney with
glomerulus. (C) It is the RE (100 mg/kg) treated kidney, represents
improvement in the glomerular structure and (D) represents glibenclamide
(10 mg/kg) treated kidney section, showing restoration of the bowman’s
space of glomerulus.
proteins (Swanston-Flatt et al., 1990). When blood glucose levels
are particularly high, some of the excess glucose pass into
the urine, which causes excess urination (reported by Diabetes
Learning Centre, 2006). Excess urination leads to increase in
water intake in case of STZ treated animal and on RE treatment,
the amount of water intake reduce to normal level in group
C (p < 0.001; Figure 2C). Moreover, the RE of MB at a dose
of 100 mg/kg showed significant improvement in FBG in STZ
treated hyperglycemic rat. Enhancement of glucokinase (GK)
activity and inhibition of glucose-6 phosphatase (G6pase) and
phosphoenolpyruvate carboxykinase (PEPCK) in the liver may be
responsible for the anti-hyperglycemic action of RE. Reduction
in the blood glucose may be the result of hepatic GK expression,
which can stimulate the residual pancreatic mechanism, probably
by accelerating the utilization of blood glucose for energy
production or glycogen storage in the liver. A decrease in G6pase
and PEPCK activities, on the other hand, indicates a decrease
in hepatic glucose production, since they are the key enzymes
involved in the regulation of gluconeogenesis and glucose output
from the liver (Son et al., 2011).
In diabetic condition, coronary artery disease is the most
common cause of death. Lipid abnormalities are commonly
associated with diabetes, particularly in those with type 2
diabetes (American Family Physician, 1999). Hyperglycemia
leads to hypertriglyceridemia due to overproduction of TG-
rich lipoproteins in the liver, associated with decreased HDL-c
and increase cholesterol levels (Abbate and Brunzell, 1990). In
STZ induced rats after RE treatment the TG, TC, LDL-c were
significantly decreased, and the level of HDL-c increased than
that of diabetic rats. Based on the results, RE seems to exert
cholesterol lowering effects. The results derived from the present
study due to RE treatment suggested that it possesses not only
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hypoglycemic property but also have hypolipidemic effect in STZ
induced hyperlipidemic rats.
Induction of OS due to depletion of antioxidant scavenger
system is the diabetogenic properties of STZ, mediated by
pancreatic β-cell destruction thereby resulting in an elevated level
of LPO that is a clear manifestation of the promotion of de
novo free radicals generation leading to tissue damage (Kaleem
et al., 2006). The significant decrease in the LPO level after
RE treatment in diabetic animals indicates that RE effectively
enhanced the antioxidant potential in vivo, by acting as a strong
O·−2 and singlet oxygen (1O2)quenchers. Tissue GSH plays a
central role in antioxidant defense by detoxifying ROS directly
or in a glutathione peroxidase-catalyzed mechanism (Ramesh
and Pugalendi, 2006). The significant decrease in GSH content
in diabetic animals was might be due to increasing utilization
of GSH against toxic effects of LPO, free radicals. RE, by
directly scavenging the free radicals in diabetic rats reduced
the utilization of GSH, thereby resulting in an increased GSH
content. Endogenous antioxidant enzymes (SOD and CAT) are
responsible for the detoxification of deleterious oxygen radicals
(Ramesh and Pugalendi, 2006). In this experiment, the SOD and
CAT activities were decreased in diabetic rats which could be
due to increase utilization for scavenging free radicals. Treatment
with RE and glibenclamide has reversed the activities of these
enzymatic antioxidants which could be a result of decreased
LPO and decreased utilization. NO synthase synthesized NO has
been implicated in a variety of pathologies including diabetes.
Aldose reductase is regulated by NO that is known to cause
hyperglycemia (Srivastava et al., 2005). After RE treatment, NO
level is reduced to the normal level which is comparable to that of
the diabetic-induced group.
Photo chemiluminescence assay is an analytical method that is
rapid, relatively simple, and reproducible, making it an attractive
bio monitoring tool especially for food supplement, nutrition and
food technologies. This study is based on the TAA, expressed
as the sum of the hydrophilic antioxidant capacity referred to
a common reference compounds, AA. This value resulted to
be a useful index to describe the capacity of complex samples
of natural origin, to counteract ROS and, in particular, the
O·−2 radical, very harmful to human health (Schlesier et al.,
2002). TAA both in the case of liver and serum, the diabetic-
induced group shows the lowest amount as compared to that
of control. In the case of RE and glibenclamide treated groups
the values of TAA were much higher than that of diabetic
animal, this might be because of the protection of different
antioxidant enzymes like SOD, GSH, CAT as reported in the
results.
Increase in the FBG and lipid levels, which was seen in
the experiment, may be responsible for the structural changes
of the pancreas in STZ treated rat (Figure 3A). Pancreatic
stellate cells activate the synthesis of free fatty acids (FFAs) and
lipid peroxide. These stellate cells help in the progression of
pancreatic fibro genesis (Fernandes-Santos et al., 2009). Fibrosis
occurs in the extracellular matrix, in which area acinar cells
disappear. The treatment of RE, reduced the progression of
fibrosis, thereby protecting the pancreas from further damage
(Figure 3C).
Histopathological studies of diabetic liver section showed a
degenerative structure with central vein congestion and cellular
swelling (Figure 4B). ROS, which was generated from STZ, may
be responsible for all these hepatic damages (Ananthan et al.,
2004; Hazarika et al., 2016). However, diabetic rats treated with
RE can restore the normal uncongested central vein (Figure 4A).
This proves that RE can protect the hepatic structure from OS
generated by STZ.
Moreover, histology of the kidney in diabetic rats showed
widening of bowman’s space area, severe hemorrhages in
glomeruli, intertubular hemorrhages and mild dilatation
(Figure 5B). Diuresis is a common feature associated with
diabetes, which may lead to the structural changes observed in
glomerulus (Shanmugasundaram et al., 1983). Enlargement of
bowman’s space is uncertain, but it may be due to glomerular
hyperfiltration rate (GFR; Henegar et al., 2001). These observed
pathological changes were decreased in RE treated diabetic rats
(Figure 5C). The glomeruli appear to be normal with mild
hemorrhages, which may be due to the protective effect of RE.
RE may decrease the GFR, which in turn may responsible for
narrowing of the bowman’s space of glomerulus.
From this study, it is inferred for the first time that the
RE of MB is a good candidate and complementary medicine
in the management of diabetes mellitus. The results of the
present study indicate that the RE is capable of exhibiting
significant antihyperglycemic activities in STZ induced diabetic
rat by improving parameters like water intake, body weight, TAA,
antioxidant enzyme and lipid profile as well as regeneration of
pancreatic islets of Langerhans, hepatic structures. The presence
of Pentacyclo[19.3.1.1(3.7).1(9.13).1(15.19)]octacosa1(25),3(28),
4,6,9(27),10,12,15(26),16,18,21,23-dodecaen-25,26,27,28-tetrol a
calyx[4]arene class of compound in RE may be responsible for the
antioxidant properties, which in turn may be partially responsible
for its antidiabetogenic and antilipidemic properties.
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